A. Rogier van der Velde

995 total citations
19 papers, 795 citations indexed

About

A. Rogier van der Velde is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, A. Rogier van der Velde has authored 19 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in A. Rogier van der Velde's work include Galectins and Cancer Biology (16 papers), Peptidase Inhibition and Analysis (9 papers) and Signaling Pathways in Disease (8 papers). A. Rogier van der Velde is often cited by papers focused on Galectins and Cancer Biology (16 papers), Peptidase Inhibition and Analysis (9 papers) and Signaling Pathways in Disease (8 papers). A. Rogier van der Velde collaborates with scholars based in Netherlands, United States and Germany. A. Rogier van der Velde's co-authors include Rudolf A. de Boer, Wouter C. Meijers, Dirk J. van Veldhuisen, Pieter Muntendam, Thor Ueland, Pål Aukrust, Aram Adourian, Anneke C. Muller Kobold, Yu Guo and Lars Gullestad and has published in prestigious journals such as Circulation, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

A. Rogier van der Velde

18 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Rogier van der Velde Netherlands 14 480 287 236 158 119 19 795
Della Cole United Kingdom 10 180 0.4× 209 0.7× 92 0.4× 179 1.1× 19 0.2× 17 641
Benjamin Lockshin United States 8 419 0.9× 130 0.5× 63 0.3× 89 0.6× 28 0.2× 13 614
Sei Tsunoda Japan 9 105 0.2× 173 0.6× 109 0.5× 56 0.4× 118 1.0× 29 580
Ayumi Niwa Japan 11 156 0.3× 45 0.2× 143 0.6× 72 0.5× 77 0.6× 31 425
Dimitar Divchev Germany 14 119 0.2× 276 1.0× 73 0.3× 146 0.9× 65 0.5× 37 577
Koichiro Abe Japan 11 81 0.2× 84 0.3× 102 0.4× 146 0.9× 83 0.7× 59 570
Haoming Song China 13 77 0.2× 156 0.5× 195 0.8× 50 0.3× 44 0.4× 56 552
Sangmee Bae United States 10 82 0.2× 73 0.3× 112 0.5× 100 0.6× 69 0.6× 23 523
Cheryl Smythe United Kingdom 5 94 0.2× 58 0.2× 135 0.6× 96 0.6× 31 0.3× 9 464
Likun Ma China 13 58 0.1× 170 0.6× 149 0.6× 122 0.8× 37 0.3× 30 540

Countries citing papers authored by A. Rogier van der Velde

Since Specialization
Citations

This map shows the geographic impact of A. Rogier van der Velde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rogier van der Velde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rogier van der Velde more than expected).

Fields of papers citing papers by A. Rogier van der Velde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rogier van der Velde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rogier van der Velde. The network helps show where A. Rogier van der Velde may publish in the future.

Co-authorship network of co-authors of A. Rogier van der Velde

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rogier van der Velde. A scholar is included among the top collaborators of A. Rogier van der Velde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rogier van der Velde. A. Rogier van der Velde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Screever, Elles M., A. Rogier van der Velde, Herman H.W. Silljé, et al.. (2023). Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance. International Journal of Molecular Sciences. 24(5). 4415–4415. 2 indexed citations
2.
Velde, A. Rogier van der, Wouter C. Meijers, Herman H.W. Silljé, et al.. (2021). Pectins from various sources inhibit galectin-3-related cardiac fibrosis. Current Research in Translational Medicine. 70(1). 103321–103321. 11 indexed citations
3.
Vegter, Eline L., Ekaterina S. Ovchinnikova, Herman H.W. Silljé, et al.. (2017). Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure. PLoS ONE. 12(5). e0177242–e0177242. 23 indexed citations
4.
Velde, A. Rogier van der, Wouter C. Meijers, Edwin R. van den Heuvel, et al.. (2016). Determinants of temporal changes in galectin-3 level in the general population: Data of PREVEND. International Journal of Cardiology. 222. 385–390. 11 indexed citations
5.
Velde, A. Rogier van der, Wouter C. Meijers, Jennifer E. Ho, et al.. (2016). Serial galectin-3 and future cardiovascular disease in the general population. Heart. 102(14). 1134–1141. 40 indexed citations
6.
Meijers, Wouter C., A. Rogier van der Velde, & Rudolf A. de Boer. (2016). ST2 and Galectin-3: Ready for Prime Time?. PubMed. 27(3). 238–52. 19 indexed citations
7.
Meijers, Wouter C., A. Rogier van der Velde, Anneke C. Muller Kobold, et al.. (2016). Variability Of Biomarkers in Patients with Chronic Heart Failure and Healthy Controls. European Journal of Heart Failure. 19(3). 357–365. 105 indexed citations
8.
Meijers, Wouter C., A. Rogier van der Velde, & Rudolf A. de Boer. (2016). Biomarkers in heart failure with preserved ejection fraction. Netherlands Heart Journal. 24(4). 252–258. 34 indexed citations
9.
Meijers, Wouter C., A. Rogier van der Velde, Domingo A. Pascual‐Figal, & Rudolf A. de Boer. (2015). Galectin-3 and post-myocardial infarction cardiac remodeling. European Journal of Pharmacology. 763(Pt A). 115–121. 73 indexed citations
10.
Velde, A. Rogier van der, Chris P. H. Lexis, Wouter C. Meijers, et al.. (2015). Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clinica Chimica Acta. 452. 50–57. 34 indexed citations
11.
Meijers, Wouter C., A. Rogier van der Velde, & Rudolf A. de Boer. (2014). The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure. Expert Review of Molecular Diagnostics. 14(3). 257–266. 34 indexed citations
12.
Velde, A. Rogier van der, Wouter C. Meijers, & Rudolf A. de Boer. (2014). Biomarkers for Risk Prediction in Acute Decompensated Heart Failure. Current Heart Failure Reports. 11(3). 246–259. 17 indexed citations
13.
Filipe, Mando D., Wouter C. Meijers, A. Rogier van der Velde, & Rudolf A. de Boer. (2014). Galectin-3 and heart failure: Prognosis, prediction & clinical utility. Clinica Chimica Acta. 443. 48–56. 56 indexed citations
14.
Boer, Rudolf A. de, A. Rogier van der Velde, Christian Mueller, et al.. (2014). Galectin-3: A Modifiable Risk Factor in Heart Failure. Cardiovascular Drugs and Therapy. 28(3). 237–246. 59 indexed citations
15.
Frenay, Anne-Roos S., Lili Yu, A. Rogier van der Velde, et al.. (2014). Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy. American Journal of Physiology-Renal Physiology. 308(5). F500–F509. 47 indexed citations
16.
Cannon, Megan V., Chris P. H. Lexis, A. Rogier van der Velde, et al.. (2014). Abstract 18491: Metformin Lowers Circulating Adiponectin Levels in Patients with Myocardial Infarction. Circulation. 130(suppl_2).
17.
Meijers, Wouter C., A. Rogier van der Velde, Willem P.T. Ruifrok, et al.. (2014). Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis. Journal of the American Heart Association. 3(5). 56 indexed citations
18.
Boer, Rudolf A. de & A. Rogier van der Velde. (2013). Galectin-3: a new biomarker for heart failure progression and prognosis. LaboratoriumsMedizin. 37(5). 251–260. 1 indexed citations
19.
Velde, A. Rogier van der, Lars Gullestad, Thor Ueland, et al.. (2013). Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure. Circulation Heart Failure. 6(2). 219–226. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Della Cole Breakdown of academic impact, for papers by Benjamin Lockshin Breakdown of academic impact, for papers by Sei Tsunoda Breakdown of academic impact, for papers by Ayumi Niwa Breakdown of academic impact, for papers by Dimitar Divchev Breakdown of academic impact, for papers by Koichiro Abe Breakdown of academic impact, for papers by Haoming Song Breakdown of academic impact, for papers by Sangmee Bae Breakdown of academic impact, for papers by Cheryl Smythe Breakdown of academic impact, for papers by Likun Ma
Rankless by CCL
2026